Premier Fund Managers LTD Gilead Sciences, Inc. Transaction History

Premier Fund Managers LTD

$2.82 Billion
Q3 2024

A detailed history of Premier Fund Managers LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Premier Fund Managers LTD holds 10,710 shares of GILD stock, worth $962,614. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,710

Previous 10,710 -0.0%

Holding current value

$962,614

Previous $737,000 21.57%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $60,556 - $73,847	846 Added 8.58%	10,710 $782,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $58,616 - $66,472	-800 Reduced 7.5%	9,864 $801,000
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $117,356 - $133,705	1,518 Added 16.6%	10,664 $869,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $11.5 Million - $16.5 Million	-184,177 Reduced 95.27%	9,146 $779,000
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $11.5 Million - $16.5 Million	184,577 Added 2110.42%	193,323 $9.7 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $199,220 - $227,561	3,346 Added 61.96%	8,746 $552,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $51,948 - $58,509	900 Added 20.0%	5,400 $1.71 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $32,439 - $36,820	500 Added 12.5%	4,500 $330,000
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $972,240 - $1.11 Million	-16,204 Reduced 80.2%	4,000 $262,000
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $104,405 - $118,965	1,843 Added 10.04%	20,204 $1.18 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $4.16 Million - $4.83 Million	-57,487 Reduced 75.79%	18,361 $1.37 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $4.75 Million - $6.08 Million	75,848 New	75,848 $5.76 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $2.67 Million - $3.11 Million	-41,129 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $1.14 Million - $1.34 Million	-16,006 Reduced 28.01%	41,129 $0
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $1.22 Million - $1.44 Million	17,208 Added 43.1%	57,135 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $264,066 - $312,991	3,662 Added 10.1%	39,927 $0
Q2 2017 Aug 14, 2017	BUY	N/A	36,265	36,265 $2.57 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.

Account

Premier Fund Managers LTD Gilead Sciences, Inc. Transaction History